MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Hardide wins contract; Trellus Health falls

ALN

The following stocks are the leading risers and fallers on AIM on Tuesday.

----------

AIM - WINNERS

----------

Hardide PLC, up 27% at 20.36 pence, 12-month range 21.70p-5.00p. The provider of advanced surface coating technology says it won a follow-on order from a customer in North America worth $1.0 million. As a result, it expects its financial performance for financial 2026 to be ahead of previous expectations.

----------

Xtract Resources PLC, up 25% at 1.00p, 12-month range 1.30p-0.40p. The Australia and Zambia-focused miner agrees to enter new joint venture for development of copper mining operations at the Zambia mining licence. It strikes the joint venture with the holder of the licence, Oval Mining, and Cooperlemon Consultancy. ‘We are pleased to have concluded this small scale copper mining agreement with Oval with respect to the Mining licence. With the continued partnership of Cooperlemon, the parties will be seeking to exploit the high grade material identified in the breccia pipe and surrounding areas,’ says Executive Chair Colin Bird.

----------

AIM - LOSERS

----------

Trellus Health PLC, down 26% at 0.70p, 12-month range 3.10p-0.32p. The healthcare company expects 2025 revenue to be $545,000. The firm reduces its monthly cash burn to around $400,000, which was ‘moderately offset’ by recurring monthly management fees during the second half of the year. The firm says it remains in ongoing discussions to find alternative sources of funding to further extend its cash runway, which currently runs to late in the first quarter. ‘We continue to manage costs and working capital carefully and are encouraged by the growing validation of our differentiated, behavioural science-based approach. We remain focused on progressing commercial discussions and look forward to updating the market on further developments,’ says Chief Executive Officer Marla Dubinsky.

----------

Copyright 2026 Alliance News Ltd. All Rights Reserved.